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Abstract  Mastitis  is  the  inﬂammation  of  breast  tissue.  From  a  pathophysiological  point  of  view,
mastitis reﬂects  a  variety  of  underlying  etiologies.  It  can  be  due  to  non-infectious  inﬂamma-
tion, infection  (generally  of  bacterial  origin)  but  can  also  be  caused  by  inﬂammation  resulting
from malignant  tumor  growth.  Mastitis  always  manifests  clinically  by  three  cardinal  signs  of
inﬂammation,  which  are  redness,  heat  and  pain.  Breast  specialists  examining  women  with  mas-
titis should  proceed  as  follows:  ﬁrst,  it  is  important  to  distinguish  between  cancer-related  and
non-cancer-related  breast  inﬂammation,  since  their  clinical  presentation  can  be  misleading.
Cancer-related  mastitis  reﬂecting  the  presence  of  aggressive  cancer  is  less  commonly  observed
than other  forms  of  mastitis  but  its  diagnosis,  which  can  sometimes  be  difﬁcult,  needs  to  be
made, or  excluded,  without  delay.  Once  cancer-related  mastitis  has  been  excluded,  the  causes
of inﬂammation  should  be  elucidated  to  enable  rapid  treatment  and  patient  recovery.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Radiological presentation of inﬂammation
The  breast  is  a  superﬁcial  organ.  The  clinical  signs  of  breast  inﬂammation  are  therefore
obvious.  They  include  redness,  heat  and  pain.  The  patient  should  be  questioned  as  to  how
inﬂammation  appeared,  and  notably  whether  it  occurred  suddenly  or  not.  Any  cases  of
inﬂammation  that  occurred  progressively  should  be  regarded  as  atypical.  As  is  the  case  in
the  rest  of  the  body,  breast  inﬂammation  may  be  of  infectious  or  non-infectious  origin,
but  it  can  also  be  caused  by  breast  cancer.
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Skin  thickening  is  one  of  the  signs  that  should  be
ought.  Although  clinical  examination  can  often  evidence
kin  thickening,  radiological  imaging  enables  detailed  anal-
sis  of  the  thickness  of  the  dermis  and  comparison  between
he  affected  and  contralateral  sides.  Clinical  examination
lone  is  insufﬁcient  to  adequately  assess  the  extent  of  skin
hickening  or  detect  limited  skin  thickening.  Mammograms
eproducibly  highlight  cases  of  dermal  thickening.  Focal
kin  lesions  are  better  visualized  by  digital  tomosynthesis
hich  provides  images  of  cross-sections  of  breast  tissue.  The
hickness  of  the  skin  can  also  be  estimated  adequately  by
ltrasound  examination  using  a  high  frequency  transducer
Fig.  1).
MRI  also  provides  precise  measurements  of  skin  thick-
ess.  Radiological  imaging  highlights  the  changes  to  adipose
issue  instigated  by  inﬂammation,  as  well  as  other  signs  of
nﬂammation.  Such  changes  are  only  very  rarely  detected
sing  mammography  or  MRI.  Ultrasound  is  very  effective  for
etecting  hyperechoic  fat  lobules  that  are  typical  ﬁndings
1]  to  look  for  inﬂammatory  breast  tissue  (Fig.  2).  The  extent
f  the  hyperechoic  zones  is  variable  and  depends  on  the
egree  of  inﬂammation.
Subcutaneous  dilatation  of  lymphatic  vessels  is  another
ardinal  sign  of  breast  inﬂammation.  Ultrasound  performs
ell  for  visualizing  this  sign  and  reveals  anechoic  slits
ocated  at  the  interface  between  the  dermis,  which  is  gen-
rally  thickened,  and  subcutaneous  fat.  Doppler  ultrasound,
hich  evidences  the  absence  of  ﬂow  (even  low  ﬂow)  within
hese  structures,  helps  distinguish  them  from  hyperemic
lood  vessels  that  are  often  associated  with  lymphatic  vessel
ilatation  (Fig.  3).
Breast  hyperemia,  deﬁned  as  increased  vascularization
f  breast  tissue,  is  also  associated  with  inﬂammation  [2].
yperemia  can  be  evidenced  by  Doppler  ultrasound  which
eveals  an  increased  number  of  arterial  and  especially
enous  structures.  Hyperemia  is  most  visible  in  the  superﬁ-
ial  regions  of  the  breast.  Such  hypervascularization  can  also
e  evidenced  by  MR  angiography  by  comparing  the  vascular
tructures  of  both  breasts  (Fig.  4).
The  possibility  of  lactiferous  duct  abnormalities  should
e  investigated  in  patients  with  breast  inﬂammation,
ecause  some  inﬂammatory  conditions  are  related  to  lac-
iferous  duct  involvement.  Ultrasound  images  can  reveal
ilated,  ectatic  ducts  with  thickened  walls  and/or  echoic
ontents.  Ultrasound  should  be  performed  from  the  nip-
le  towards  peripheral  zones  following  a  radial  pattern
o  detect  possible  abnormalities  within  each  breast  seg-
ent.  Mammography  is  generally  not  of  much  help  when
xamining  lactiferous  ducts,  because  the  latter  are  not  visi-
le  on  mammograms.  Sometimes  however,  the  lactiferous
ucts  can  be  visualized  by  mammography  in  very  dense
r  very  fatty  breasts  and  lactiferous  duct  abnormalities
an  be  observed.  MRI  is  an  appropriate  imaging  modality
or  examining  the  lactiferous  duct  system  due  to  its  high
patial  resolution  and  use  of  contrast.  Indeed,  the  inﬂamma-
ory  involvement  of  lactiferous  ducts  can  be  determined  by
njection  of  contrast  medium  and  assessing  wall  thickening
Fig.  5).Radiologists  examining  patients  with  breast  inﬂammation
hould  take  particular  care  to  detect  possible  ﬂuid  collec-
ions.  Initial  ﬂuid  collections  within  the  breast  can  be  small
nd  difﬁcult  to  detect  as  they  are  only  very  slightly  more
i
i
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ypoechoic  than  the  neighboring  breast  tissue.  They  are
ractically  always  accompanied  by  hyperechoic  changes  to
he  surrounding  fat.  If  a  ﬂuid  collection  is  evidenced,  its
ontents  are  generally  found  to  be  hypoechoic,  but  remain
eterogeneous.  Typically,  it  features  a  ﬂuid-ﬂuid  level.  The
alls  of  ﬂuid  collections  can  appear  as  thickened  or  irregular
nd  tend  to  spread  to  and  dissect  neighboring  fat  lobules
Fig.  6).  Radiologists  should  search  for  possible  ﬁstula  paths
owards  the  skin  or  lactiferous  ducts.
The  axilla  of  patients  with  breast  inﬂammation  should
e  examined  to  determine  possible  lymph  node  involve-
ent.  Lymphadenopathy  can  be  a  reaction  to  inﬂammation
r  secondary  to  metastasis  in  patients  with  inﬂammatory
reast  cancer.  Lymph  nodes  with  regular  cortical  thickening,
mooth  borders  and  a  visible  central  hilum  generally  reﬂect
 benign  condition.  On  the  contrary,  malignancy  is  charac-
erized  by  focal  or  off-center  cortical  thickening  combined
ith  abnormalities  of  lymph  node  borders  with  inﬁltration
f  the  adipose  tissue  and  disappearance  of  the  central  hilum
Fig.  7).
maging techniques
s  discussed  hereafter,  breast  inﬂammation  can  arise  from
 variety  of  etiologies,  some  of  which  can  be  difﬁcult  to
iagnose.  Full  use  of  breast  imaging  techniques  is  there-
ore  crucial  to  ensure  diagnosis  is  as  precise  as  possible
nd  subsequently  to  provide  the  patient  with  the  most  efﬁ-
ient  treatment.  To  do  this,  it  is  advisable  to  make  use  of
he  whole  range  of  diagnostic  methods,  without  trying  to
ut  expenses.  Technically,  the  choice  of  modalities  should
epend  on  available  human  and  technical  expertise  and  the
linical  setting  that  should  take  into  account  the  patient’s
ge.
ammography
ammography  should  be  proposed  to  patients  aged  over  30
ears  presenting  with  breast  inﬂammation.  The  imaging  pro-
edure  should  be  adapted  in  each  case  to  accommodate
he  pain  experienced  by  patients  with  breast  inﬂamma-
ion.  An  acceptable  compromise  must  be  found  between
he  need  for  sufﬁcient  image  quality  and  the  pain  caused
o  the  patient  by  breast  compression.  Although  mammo-
ram  quality  can  sometimes  be  suboptimal  due  to  issues
elated  to  breast  compression,  the  images  obtained  can
rovide  crucial  information  for  diagnosing  and  managing
he  patient’s  condition.  Bilateral  mammography  should  be
erformed  in  order  to  compare  the  healthy  and  affected
reast.  Indeed,  the  detection  of  speciﬁc  details  on  the
ffected  side  involves  comparison  with  the  contralateral
ide  and  the  unaffected  side  also  needs  to  be  screened
or  clinically  undetected  disease.  Careful  examination  of
ammograms  is  required  to  detect  possible  nodular  zones,
rchitectural  distortion  or  microcalciﬁcations.  Even  dis-
reet  details  that  do  not  generally  raise  suspicion  may
rove  decisive  for  the  diagnosis  and  management  of  breast
nﬂammation.  It  can  therefore  be  helpful  to  use  enlarged
mages  and  digital  tomosynthesis  to  visualize  such  details
3].
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Figure 1. Skin thickening. a: mammogram (MLO view) shows thickening of the skin of the right breast; b: enlarged image of 1a shows
asymmetric skin thickness, particularly visible in the lower quadrant (white arrow); c: ultrasound examination shows thickening of the
 thick
p
t
t
udermal layer; d: ultrasound images of right and left breasts show
arrow).
Ultrasound
Ultrasound  examination  is  crucial  for  assessing  patients  with
breast  inﬂammation.  Ultrasound  should  be  performed  on  a
systematic  basis,  should  be  bilateral  and  include  examina-
tion  of  axillary  lymph  nodes.  The  radiologist  should  always
search  for  signs  of  inﬂammation  and  attempt  to  clearly
identify  the  area  affected  by  the  inﬂammatory  process.  In
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Figure 2. Hyperechoic fat. a: normal right breast; b: left breast wit
ultrasound beam due to attenuation; c: fat hyperechogenicity is focusedening of the skin and normal skin thickness, respectively (white
atients  with  inﬂammatory  breast  cancer,  ultrasound  helps
o  locate  ﬂuid  collections  and  provides  images  that  suggest
he  presence  of  tumor  growth.  Finally,  ultrasound  can  be
sed  to  plan  and  guide  percutaneous  sampling  procedures
hich  are  an  essential  part  of  the  diagnostic-  and  treatment-
lanning  process.  Ultrasound  can  also  be  used  to  guide  tissue
iopsies  of  lymph  nodes  in  patients  with  suspected  lymph
ode  involvement.
h diffuse hyperechoic fat and reduced penetration depth of the
 around a central hypoechoic collection.
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Figure 3. Visibility of subcutaneous lymphatic vessels. a: ultrasound examination reveals thickening of the skin and hypoechoic slits
between the dermal and hypodermal layers; b: same image as (a) in Doppler mode. Detection of a Doppler signal within the vascular
structures. The slits remain hypoechoic and unvascularized, and reﬂect lymph vessel ectasia; c: ultrasound examination allows distinguishing
b respe
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B
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Uetween increased blood vessels and distended lymph vessels that 
: Doppler ultrasound can be used to distinguish between blood vesreast MRI
reast  MRI,  which  requires  the  injection  of  contrast  medium,
hould  only  performed  in  speciﬁc  circumstances.  It  is  often
p
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igure 4. Increased vascularization. MR image of a woman with left bre
isible on this fat-saturated T1-weighted image with MIP reconstructio
ltrasound examination of mastitis. Same image as (b) using Doppler ultctively show up as vascular slits with or without a Doppler signal;
and distended lymph vessels.erformed  once  an  inﬂammatory  carcinoma  has  been  diag-
osed  and  is  aimed  at  providing  more  detailed  information
n  tumor  development.  MRI  provides  more  detail  on  possible
eep  involvement  and  can  reveal  signs  of  inﬂammation  of
ast inﬂammation shows increased vascularization that is particularly
n following intravenous administration of a gadolinium chelate.
rasound reveals increased vascularization of breast tissue.
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Figure 5. Lactiferous duct changes. Ultrasound examination showing an ectatic lactiferous structure with regular borders in the retroare-
olar region. Ultrasound examination showing lactiferous duct ectasia with intraductal hyperechoic nodular changes that reﬂect the presence
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characterized  by  diffuse  inﬁltration  of  breast  tissue  and  theof thick inﬂammatory secretions (arrow). Fat-saturated T1-weighte
a gadolinium chelate shows distended lactiferous ducts with pariet
underlying  muscles  and  chest  structures.  It  is  used  to  detect
lymphadenopathy  of  the  internal  mammary  lymph  nodes
that  is  difﬁcult  to  detect  via  ultrasound.  It  also  performs
better  for  evaluating  the  involvement  of  axillary  and  apical
lymph  nodes.  If  malignancy  is  detected,  the  contralateral
breast  should  be  examined  using  a  high  sensitivity  modality,
such  as  MRI,  to  exclude  tumor  development  on  the  contralat-
eral  side.  Patients  with  inﬂammatory  carcinoma  generally
receive  neoadjuvant  chemotherapy  before  surgical  manage-
ment  is  considered.  In  these  cases,  MRI  is  the  best  modality
for  monitoring  disease  progression  and  patient  response  to
chemotherapy.  MRI  can  also  be  performed  in  patients  pre-
senting  with  ostensibly  non  tumor-related  inﬂammation  but
that  seems  atypical  or  progresses  in  an  unusual  way,  as  well
as  in  patients  for  who  neither  mammography,  ultrasound
nor  percutaneous  sampling  has  led  to  diagnosis.  In  such
circumstances,  MRI  can  reveal  breast  tumors  that  remain
undetectable  using  conventional  techniques.
Percutaneous  samples  should  be  collected  rapidly  from
patients  with  breast  inﬂammation.  Percutaneous  sampling
procedures  are  in  principle  guided  by  ultrasound  that  reveals
presence  of  the  abnormality(ies)  (generally  collections  or
hypoechoic  zones  that  may  reﬂect  developing  ﬂuid  col-
lections  or  tumor  masses).  Due  to  the  broad  spectrum  of
possible  diseases  that  can  cause  breast  inﬂammation,  his-
tological  analysis  of  pathological  samples  seems  advisable.
Cytological  and  bacteriological  analysis  of  the  ﬂuid  collected
during  these  procedures  is  also  mandatory.  When  performed
in  a  timely  manner  (if  possible  during  the  ﬁrst  visit),  such
histocytological  and  bacteriological  samples  help  to  move
quickly  through  the  diagnostic  process.If  breast  cancer  is  suspected,  even  if  a  clear  target
lesion  has  not  been  identiﬁed,  samples  should  be  obtained
from  areas  of  minor  change  detected  using  ultrasound.  This
s
c
c images in the axial plane following intravenous administration of
ancement.
ften  enables  diagnosis  based  on  histological  results  because
nﬂammatory  cancers  show  diffuse  tissue  involvement  with
ymphangitic  carcinomatosis  throughout  the  breast.  Sam-
les  from  even  seemingly  unaffected  zones  can  therefore
ften  lead  to  diagnosis.  In  patients  with  proven  ﬂuid  col-
ection(s),  immediate  puncture  aspiration  of  the  collection
educes  necrotic  abscess  volume  and  promotes  efﬁcient
nti-inﬂammatory  and  anti-infective  treatment.  In  rare
ases,  mammography  data  is  sufﬁcient  to  guide  stereotactic
ample  collection,  particularly  in  patients  with  microcalci-
cation  clusters.
MRI-guided  biopsies  are  generally  only  considered  when
o  clear  target  can  be  seen  on  mammograms  or  ultrasound
mages  and  MRI  reveals  the  presence  of  a  suspicious  focal
arget.
iagnostic approaches and management of
reast  inﬂammation
nﬂammatory cancer
n  the  great  majority  of  cases,  breast  inﬂammation  is  caused
y  an  inﬂammatory  or  infectious  disease  of  breast  tissue;
owever  sometimes  it  can  be  due  to  inﬂammatory  cancer.
lthough  inﬂammatory  breast  cancer  is  clinically  quite  rare,
adiologists  specializing  in  breast  disease  must  be  familiar
ith  its  signs  and  be  able  to  diagnose  it  without  delay  [4,5].
nﬂammatory  cancer  is  an  aggressive  form  of  invasive  cancerudden  onset  of  symptoms.  Typically,  inﬂammatory  breast
ancer  is  diagnosed  within  3  months  of  the  onset  of  clini-
al  symptoms.  Patients  present  with  diffuse  breast  edema
1050  D.  Lepori
Figure 6. Fluid collection. Ultrasound examination shows a hypoechoic area of approximately 1 cm, surrounded by highly hyperechoic fat.
The central hypoechoic zone is a developing ﬂuid collection. Ultrasound examination shows a ﬂuid collection measuring 2.2 cm in diameter,
with a horizontal ﬂuid level (arrowhead) as well as wall thickening. Ultrasound examination shows a ﬂuid collection (diameter 2.5 cm)  within
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fhe breast with poorly deﬁned borders and tending to inﬁltrate ne
ithin the breast with relatively well-deﬁned borders and extendin
isible  by  clinical  examination  with  ‘‘orange  peel’’  skin  or
rythema.  The  entire  breast  is  usually  swollen  and  no  real
alpable  masses  are  detected.  It  is  estimated  that  3  to  10%
f  invasive  cancers  show  the  clinical  signs  of  inﬂammatory
ancer.
Minimum  criteria  for  diagnosing  inﬂammatory  carci-
oma  include:  skin  changes  (erythema,  edema,  orange
eel,  redness  and  heat);  clinical  history  of  less  than  6
onths;  erythema  covering  at  least  one  third  of  the  breast;
istopathological  evidence  of  invasive  carcinoma  [6].
The  typical  clinical  presentation  of  skin  inﬂammation  is
 consequence  of  tumor  cell  emboli  within  the  lymphatic
essels  that  are  mainly  subcutaneous  in  the  breast.  Lym-
hangitic  carcinomatosis  of  the  skin  therefore  characterizes
nﬂammatory  cancers,  but  it  is  neither  indispensable  nor
ufﬁcient  to  diagnose  inﬂammatory  carcinoma.
Inﬂammatory  cancer  must  be  distinguished  from  late-
tage  localized  cancer  with  skin  involvement.  Inﬂammatory
ancer  is  generally  characterized  by  the  recent  history  of
ymptoms  (<  3  months)  in  relatively  young  women  (average
s
m
mring tissues. Ultrasound examination shows ﬂuid collection > 3 cm
ng fat lobules.
ge:  58  years),  diffuse  cutaneous  signs,  the  presence  of  a
elatively  fast-developing  growth  as  well  as  a  relatively  high
ate  of  metastasis  at  diagnosis  (estimated  at  20—40%).  These
ancers  are  generally  of  poor  prognosis  and  the  survival  rate
t  2  years  is  84%.
Late-stage  localized  cancers  are  usually  characterized  by
 long  clinical  history  and  a mass  that  has  been  present  for
ore  than  6  months.  Skin  involvement  is  often  localized  to
 speciﬁc  part  of  breast.  The  inﬂammatory  form  of  such
ancers  generally  occurs  in  older  women  (average  age:  66
ears).  Tumor  growth  is  slow  and  only  10%  of  women  have
etastases  at  diagnosis.  The  prognosis  of  these  cancers  is
ore  favorable  with  a  survival  rate  at  2  years  of  91%.
Imaging  techniques  often  enable  radiologists  to  evidence
nd  diagnose  breast  cancer.  Mammographic  ﬁndings  often
eveal  signiﬁcant  asymmetry  with  skin  thickening  and  dif-
use  edema  of  the  breast.  Although  sometimes  easy  to
ee,  breast  cancer  is  often  reﬂected  by  only  subtle  mam-
ographic  details  so  mammograms  should  be  reviewed
eticulously.  Image  enlargement  can  help  to  evidence
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Figure 7. Lymphadenopathies. Lymph node enlargement in a patient with malignant disease (1.6 cm). Off-center hilum (arrowhead)
and signiﬁcant asymmetric, cortical thickening. Lymph node enlargement in a patient with malignant disease (1.8 cm) in association with
complete disappearance of the hilum. Ultrasound examination of lymphadenopathy in a patient with inﬂammatory disease. The hilum is still
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dvisible and associated with regular cortical thickening. Adenomega
the lymph node hilum remains visible (arrow) and cortical thickenin
microcalciﬁcations, the  presence  of  which  is  always  highly
suspicious  in  these  circumstances.  Localized  compression  or
digital  tomosynthesis  images  can  reveal  opacities  (gener-
ally  spiculated)  or  asymmetric  density  that  are  also  highly
suspicious  in  patients  with  breast  inﬂammation  (Fig.  8).
Ultrasound  examination  shows  the  previously  described
inﬂammatory  signs,  but  should  be  used  to  detect  possible
breast  tumors  (masses)  or  attenuated  or  hypoechoic  zones
from  which  percutaneous  samples  can  be  collected  for  his-
tological  diagnostic  techniques.  Investigation  of  the  lymph
nodes  of  the  axillary  region  can  provide  information  point-
ing  towards  breast  cancer;  possible  lymph  node  involvement
should  spur  radiologists  to  collect  tissue  or  cell  samples  for
further  analysis.
Breast  MRI  is  generally  performed  in  patients  with  inﬂam-
matory  cancer.  It  provides  detailed  information  on  the
spread  of  cancer  cells  within  the  breast  tissue  and  lymph
node  involvement  (especially  apical  and  internal  mammary
groups).  MRI  is  also  used  to  detect  possible  contralateral
lesions  that  might  not  have  been  detected  during  the  ini-
tial  mammographic  and  ultrasound  examinations  in  patients
with  patent  homolateral  breast  cancer.  MRI  guidance  helps
radiologists  collect  percutaneous  biopsies  by  subsequently
targeting  a  zone  delimited  by  MRI  using  ultrasound  guid-
ance  [7].  In  patients  for  whom  such  ultrasound-guided  biopsy
techniques  do  not  provide  adequate  tissue  samples,  real-
time  MRI-guided  biopsies  should  be  considered.  The  ﬁrst-line
T
i
w
tngitudinal diameter: 2 cm. In patients with inﬂammatory disease,
egular.
reatment  of  inﬂammatory  cancers  is  generally  neoadjuvant
hemotherapy.  In  such  cases,  pretreatment  MRI  allows  radio-
ogists  to  subsequently  and  reliably  assess  the  efﬁcacy  of
herapy.  From  time  to  time,  radiologists  strongly  suspect
nﬂammatory  carcinoma  without  being  able  to  identify  a
lear  target  for  percutaneous  sampling  by  mammography,
ltrasound  or  MRI.  Such  cases  generally  reﬂect  very  diffuse
reast  cancer  (Fig.  9)  and  percutaneous  samples  should  be
aken,  without  proper  radiological  guidance,  from  the  areas
hat  clinically  seem  to  be  most  affected.  By  proceeding
his  way,  reliable  diagnostic  results  can  be  obtained  for
atients  with  inﬂammatory  breast  cancer.  If  despite  all  these
iagnostic  procedures,  inﬂammatory  cancer  is  still  clinically
uspected  but  cannot  be  evidenced  histologically  based  on
he  different  percutaneous  samples  obtained,  a  multidis-
iplinary  case  assessment  meeting  should  be  scheduled  to
etermine  the  appropriate  diagnostic  approach  (which  is
ften  based  on  excisional  biopsy).
uerperal mastitis
he  diagnosis  of  puerperal  mastitis  is  frequently  quite  easy
ue  to  the  clinical  circumstances  in  which  it  arises  [8,9].
his  form  of  mastitis  occurs  in  breast-feeding  women.  Dur-
ng  its  initial  stages,  puerperal  mastitis  results  in  milk  stasis
hich  is  often  due  to  a  poor  anatomical  drainage  of  part  of
he  breast.  At  this  stage,  leukocyte  and  bacterial  counts  in
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Figure 8. Inﬂammatory carcinoma of the right breast. Mammogram of the right breast shows substantial thickening of the skin of the
breast and diffuse edema of the right breast tissue. Magniﬁed craniocaudal (CC) view mammogram shows a few calciﬁcations categorized
as BI-RADS 4. Tomosynthesis images shows a mass with complex shape and irregular borders. Breast ultrasound shows an irregularly shaped
nodular structure with poorly deﬁned borders which is a tumor. Fat-saturated T1-weighted MR images in the axial plane following intravenous
administration of a gadolinium chelate show spiculated tumor masses with multiple areas of enhancements as well as thickening of the skin.
Fat-saturated T2-weighted MR images show hyperintensity of the cutaneous tumor masses, as well as an extended pectoralis major muscle
with high signal intensity zones (arrow). Fat-saturated T1-weighted MR images in the axial plane of the axilla region following intravenous
administration of a gadolinium chelate show asymmetry of both lymph node size and appearance. Metastatic involvement of some of the
lymph nodes of the right axilla region is probable (arrowhead).
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the  milk  are  low.  Most  cases  of  milk  stasis  do  not  require
herapeutic  management  and  resolve  spontaneously.  How-
ver,  if  milk  stasis  persists,  non-infectious  inﬂammation
ppears.  It  is  associated  with  an  increased  milk  leukocyte
ount,  although  the  bacterial  count  does  not  change  signiﬁ-
antly.  Fifty  percent  of  cases  of  non-infectious  inﬂammation
ventually  result  in  infectious  mastitis,  characterized  an
ncreased  milk  leukocyte  count,  as  well  as  a  signiﬁcant
ncrease  in  the  number  of  bacteria  in  the  milk.  In  90%  of
ases,  patients  with  infectious  mastitis  recover  following
s
c
T
gnti-inﬂammatory  and  antibacterial  treatment.  In  10%  of
ases,  the  patients  develop  a breast  abscess  which  tends
o  complicate  treatment.
In  breast-feeding  women  with  breast  inﬂammation,
ltrasound  should  be  performed  to  search  for  ﬂuid  collec-
ion.  If  ultrasound  evidences  ﬂuid  collection,  percutaneous
ampling  and  drainage  of  the  ﬂuid  collection  should  be
onsidered  and  performed  in  a  timely  manner  (Fig.  10).
his  will  allow  more  accurate  diagnosis  and  above  all  tar-
eted  antibiotic  treatment  against  the  bacteria  detected
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Figure 9. Inﬂammatory cancer. Comparison of right (normal) and left (pathological) mammograms in a patient with inﬂammatory carci-
noma. CC view. Left breast: diffuse cutaneous edema and breast edema. Discreet architectural distortion, but no unequivocal mass observed
on mammography. Ultrasound examination of the left axilla region shows enlarged lymph node, the hilum of which has practically com-
pletely disappeared. Ultrasound examination of the left breast shows a thickening of the skin and signiﬁcant dilation of lymphatic vessels
within the subcutaneous fat. Skin histology showing tumor cells within distended lymphatic vessels in the dermis, a hallmark of lymphangitic
carcinomatosis (arrowhead). The lymphatic nature of the vessel was established by immunohistochemistry.
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win  the  collection.  In  patients  with  a  recurrent  ﬂuid  col-
lection,  drainage  may  be  repeated  but  if  the  collection
persists  or  recurs  again,  and  especially  if  sized  >  3  cm,  the
placement  of  a  percutaneous  drainage  catheter  should
be  considered  and  discussed  with  the  treating  physician
[10—13]  (Fig.  11).  Only  in  the  event  of  recurrent  ﬂuid
collections,  and  inconclusive  percutaneous  drainage  and
placement  of  a  percutaneous  drainage  catheter,  the  possibil-
ity  of  referring  the  patient  to  a  surgeon  for  surgical  drainage
should  be  considered.  Although  previously  used  in  cases
of  puerperal  abscess,  surgical  drainage  is  now  rarely  per-
formed  due  to  the  effectiveness  of  percutaneous  procedures
and  antibiotics.  The  possibility  of  carcinoma  should  not
be  neglected  in  breast-feeding  women  with  breast  inﬂam-
mation.  In  these  patients,  cancer  can  sometimes  develop
rapidly  with  signs  of  breast  inﬂammation  consistent  with
mastitis.
If  clinical  examination  seems  suspicious  or  ultrasound
images  appear  unusual,  then  mammography  can  sometimes
reveal  suspicious  abnormalities  that  allow  more  accurate
diagnosis.  Percutaneous  sampling  in  breast-feeding  women
with  atypical  imaging  ﬁndings  can  prevent  misdiagnos-
ing  cancer  which,  although  rare,  is  difﬁcult  to  diagnose
(Fig.  12).
t
a
gnﬂammation of the nipple-areola complex
he  nipple  and  the  nipple-areolar  complex  (NAC)  form  a
peciﬁc,  complicated  anatomical  entity  within  the  breast.
natomically,  they  form  a  hub  into  which  ﬂow  the  lactifer-
us  ducts  that  drain  the  breast  tissue.  In  addition,  numerous
pocrine  glands  such  as  sebaceous  and  sweat  glands,  as  well
s  Montgomery  glands  are  located  in  the  NAC  [14].  Mont-
omery  glands  are  small  glandular  units  that  are  located
ust  beneath  the  surface  of  the  skin  on  the  edge  of  the
reola.  Montgomery  glands  communicate  directly  with  the
xternal  environment  and  can  therefore  become  contami-
ated  by  bacteria.  For  these  reasons,  breast  inﬂammation
f  infectious  origin  often  begins  and  spreads  from  the  NAC.
Radiological  investigation  of  the  NAC  and  neighboring
issue  is  challenging  due  to  its  small  anatomical  size  and
ts  superﬁcial  position.  The  usefulness  of  mammography  for
nvestigating  the  NAC  is  quite  poor  and  ultrasound  exami-
ation  is  difﬁcult  because  of  the  acoustic  shadow  cast  by
he  anatomy  of  the  nipple  due  to  diffraction  of  ultrasound
aves.  Clinical  examination  is  therefore  of  utmost  impor-
ance  for  this  region  of  the  breast.  Most  nipple  conditions
re  caused  by  inﬂammation  or  infection  of  Montgomery
lands.  They  are  associated  with  lesions  located  within  the
1054  D.  Lepori
Figure 10. Puerperal mastitis of the left breast. Ultrasound examination of the right breast reveals hyperechoic breast tissue that typically
characterizes hypertrophic glandular tissue in nursing women. Left breast: substantial duct ectasia near to the zone clinically affected by
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dastitis. Echoic, poorly delimited ﬂuid collection inﬁltrating the b
nlarged lymph node (arrow).
ermis  (dermoid  or  epidermoid  cysts)  and  inﬂammation  of
eighboring  tissue,  or  direct  suppuration  from  sebaceous  or
weat  glands.  Radiological  examination  reveals  an  intrader-
al  lesion  with  inﬂammatory  signs  that  can  spread  into  the
ubcutaneous  layer  and  the  superﬁcial  portion  of  the  breast
Fig.  13).  In  such  situations,  diagnostic  and  therapeutic
nterventional  procedures  are  of  little  help.  Percutaneous
ampling  is  difﬁcult  because  of  the  very  superﬁcial  location
f  the  lesions  and,  by  their  very  nature  (dense  structures),
hey  cannot  be  drained  adequately  using  percutaneous  pro-
edures.  NAC  lesions  should  therefore,  in  the  ﬁrst  instance,
e  treated  by  drug  therapy.  Should  resistance  to  drug  ther-
py  or  recurrence  be  observed,  surgical  excision  should  be
onsidered.
Radiologists  should  be  familiar  with  a  speciﬁc  clinical
ondition  called  Zuska’s  disease  [15]  and  also  known  as  lact-
ferous  ﬁstula  or  subareolar  abscess,  and  be  able  to  diagnose
t  in  patients  with  NAC  inﬂammation.  It  is  a  largely  unknown
isease  characterized  by  repeated  and  recurrent  episodes
ith  a  speciﬁc  clinical  presentation.  Patients  present  with
nﬂammatory  abscesses  and  a  ﬁstula  that  generally  opens
n  the  edge  of  the  areola  or  in  the  breast  tissue  close
o  the  NAC.  The  pathophysiological  mechanism  underlying
his  disease  is  based  on  changes  of  the  epithelium  lining
he  lactiferous  ducts  where  they  drain  into  the  nipple.
he  epithelium,  which  usually  consists  of  a  double  layer
f  cuboidal  cells,  becomes  squamous  and  thickens  caus-
ng  lactiferous  duct  obstruction.  Duct  obstruction  leads  to
ecretory  stasis  of  the  distal  part  of  the  lactiferous  duct  and
ppearance  of  an  abscess  in  the  retroareolar  region.  The
ontinuing  inﬂammatory  process  results  in  the  formation  of
s
w
l tissue. Ultrasound examination of the left axilla region shows an
 ﬁstula  in  the  periareolar  region.  Because  it  is  relatively
nknown,  Zuska’s  disease  (duct  obstruction,  abscess  and  ﬁs-
ula)  is  often  managed  by  surgical  ablation  of  the  ﬁstula  and
he  abscess.  In  these  cases,  the  lactiferous  duct  causing  the
isease  remains  in  place,  and  leads  inevitably  to  recurrent
ocal  outbreaks  of  the  condition.  Only  appropriate  surgical
anagement  removing  the  ﬁstula  path,  the  abscess  and  the
bstructed  lactiferous  duct  allows  complete  recovery  from
his  disease  (Figs.  14  and  15).
alactophoritis and peripheral breast abscess
ven  if  initially  located  in  the  nipple  region,  lactiferous
uct  infection  can  spread  in  a  retrograde  manner  to  the
ntire  lactiferous  system  and  cause  widespread  lactiferous
nd  breast  inﬂammation.  In  such  cases,  the  breast  shows
igniﬁcant  diffuse  inﬂammation  and  differential  diagnosis
etween  inﬂammation  of  infectious  origin  and  inﬂamma-
ory  carcinoma  can  be  difﬁcult.  Radiological  investigation
f  these  patients  shows  abnormalities  of  both  the  central
nd  peripheral  lactiferous  system.  Ultrasound  examination
eveals  signiﬁcant  duct  ectasia  and  duct  contents  are  some-
imes  visualized  as  a  dense  ﬂuid  but  are  often  solid  (Fig.  16).
ammography  is  usually  not  very  helpful  and  mostly  shows
igns  of  edema  without  substantial  ﬂuid  collection.  MRI,
owever  evidences  widespread  lactiferous  involvement  with
iffuse  signs  of  inﬂammation  and  no  suspicious  tumor  masses
uggesting  the  diagnosis  of  galactophoritis.
Peripheral  breast  abscesses  generally  occur  in  women
ith  preexisting  cystic  lesions  (Fig.  17).  Such  patients  have  a
ong  history  of  cystic  breast  disease  with  a  painful  palpable
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Figure 11. Fluid collection in patients with puerperal mastitis and percutaneous drainage. Slight duct ectasia without ﬂuid collection in
a patient with puerperal mastitis. One-centimeter ﬂuid collection in a patient with puerperal mastitis. Substantial ﬂuid collection (> 5 cm),
a patient with puerperal mastitis. Ultrasound-guided drainage of the collection shown in (c); needle located inside the ﬂuid collection.
Subtotal drainage of the collection shown in (c) after withdrawal of 8 mL of pus.
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tnodule  and  signs  of  localized  inﬂammation.  The  diagnosis
of  peripheral  abscesses  using  ultrasound  can  sometimes  be
challenging  due  to  the  difﬁculty  of  visualizing  an  abscess  in
the  middle  of  numerous  other  cystic  lesions.  A  lesion  is  sus-
pected  to  be  inﬂammatory  based  on  subtle  signs  of  the  cystic
wall,  notably  thickening,  wall  fragmentation  or  abnormal
contents  (Fig.  18).  Percutaneous  puncture  can  lead  to  diag-
nosis  while  allowing  collections  to  be  drained  and  therefore
faster  recovery.
Granulomatous mastitis
Granulomatous  mastitis  is  an  inﬂammatory  condition  of
non-infectious  origin  that  speciﬁcally  affects  breast  tissue.
From  a  histopathological  point  of  view,  it  is  caused  by  a
granulomatous  inﬂammatory  response  containing  giant  cells
[16—18].  Its  etiology  is  unknown.  Granulomatous  mastitis
generally  occurs  in  young  women,  often  after  a  breast-
feeding  period,  and  within  a  period  of  5  years  following
childbirth.  Clinically  it  is  characterized  either  by  a  local-
ized  palpable  mass  with  lymph  node  enlargement,  or  by
a  more  diffuse  condition  (Figs.  19—21).  In  the  majority  of
f
c
aases,  it  is  not  associated  with  the  clinical  signs  of  inﬂamma-
ion,  but  sometimes  such  signs  can  predominate.  When  the
nﬂammatory  component  is  signiﬁcant,  aseptic  abscesses
re  frequently  observed  with  formation  of  a  ﬁstula  between
he  abscess  and  the  skin.  The  presentation  of  granuloma-
ous  mastitis  is  very  variable  and  all  the  different  signs  of
nﬂammation  can  be  observed  including  ﬂuid  collections,
utaneous  symptoms  and  lymph  node  enlargement.  The
resence  of  multiple  lesions  and  lymph  node  enlargement
imics  multifocal  breast  cancer  with  lymph  node  involve-
ent.  The  diagnosis  can  be  made  by  histological  analysis  of
ercutaneous  samples;  it  is  indeed  rarely  made  simply  on  the
asis  of  clinical  signs  and  radiological  ﬁndings.  In  the  initial
tages  of  the  disease,  before  histological  analysis  is  per-
ormed  and  due  to  the  absence  of  positive  results  following
acteriological  testing,  patients  with  granulomatous  masti-
is  are  often  ﬁrst  treated  to  no  avail  with  anti-inﬂammatory
rugs  and  the  standard  antibiotics  used  for  infectious  mas-
itis.  Some  patients  are  wrongly  referred  to  cancer  centers
or  probable  inﬂammatory  cancer.  Such  erroneous  diagnoses
an  be  corrected  by  obtaining  percutaneous  tissue  samples
nd  histological  results  showing  a  granulomatous  response
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Figure 12. Invasive carcinoma of the right breast in a nursing patient. Ultrasound examination shows a 3-cm, hypoechoic structure with
heterogeneous content and poorly deﬁned borders. MLO mammograms of the right and left breast show an asymmetric tissue mass consistent
with the palpable lump found on the right side but not on the left. Enlargement of mammogram (b) shows a few rare calciﬁcations within
the mass. Doppler ultrasound shows that the lesion is vascularized and that it is a solid mass and not a collection of ﬂuid.
Figure 13. Left periareolar inﬂammatory lesion due to an infected dermoid cyst. Left tomosynthesis CC view shows thickening of the
skin in the periareolar region. Enlargement of tomosynthesis image (a) shows a thickening of the left nipple-areola complex. Ultrasound
examination of the left nipple-areola complex shows thickening of the dermis (arrowhead). Intradermal ﬂuid collection (width: 1 cm) in
contact with underlying lactiferous ducts.
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Figure 14. Non-puerperal subareolar mastitis (Zuska’s disease) of the left breast. Ultrasound examination of the periareolar region of
left breast performed in 2008 shows a hypoechoic collection with a duct-like structure extending towards the nipple (arrowhead). Left
periareolar breast ultrasound performed in 2012. Clinical examination reveals a periareolar ﬁstula. Ultrasound examination shows a dilated
lactiferous duct draining into the area of the cutaneous ﬁstula (arrow). Mammogram performed in 2012 shows areolar thickening without a
detectable breast mass.
Figure 15. Non-puerperal subareolar mastitis (Zuska’s disease) of the left breast (same patient as Fig. 14). a: breast MRI shows
enhancement of the lactiferous ducts of the left retroareolar region (arrow) after intravenous administration of a gadolinium chelate; b:
reconstruction of thick T1-weighted fat-saturated MR images after intravenous administration of a gadolinium chelate shows an enhanced
lactiferous duct that extends towards a skin ﬁstula; c, d and e: three enlarged T1-weighted fat-saturated images after intravenous adminis-
tration of a gadolinium chelate show the path of the ﬁstula in the periareolar region (arrow) and the opening of the thickened and widened
lactiferous duct on the nipple (arrowhead).
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Figure 16. Extensive mastitis of the lactiferous ducts of the left breast. Mammogram, left breast, MLO view, shows breast and cutaneous
edema as well as increased tissue density for the whole breast. Breast ultrasound shows widened lactiferous ducts, seen here on transverse
images of the central portion of the breast. Fat-saturated T1-weighted MR images in the transverse plane after intravenous administration
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pf a gadolinium chelate show widened lactiferous ducts with enhan
ontaining  typical  giant  cells.  In  particular  circumstances,
peciﬁc  infectious  diseases  (for  example  tuberculosis)  that
an  lead  to  formation  of  granuloma  need  to  be  excluded.
Once  histological  evidence  of  granulomatous  mastitis
as  been  obtained,  patients  should  receive  systemic  oral
teroids  which  lead  to  full  recovery  from  this  disease.
urgery  is  rarely  called  for  due  to  the  efﬁcacy  of  systemic
teroid  treatment  and  should  only  be  used  in  patients  with
ecurrent  episodes  or  who  do  not  respond  to  steroid  treat-
ent.
are forms of mastitis
are  forms  of  mastitis  caused  by  exposure  to  speciﬁc  orga-
isms  should  be  considered  in  special  conditions  [19].  In
atients  with  penetrating  wounds  by  thorns  associated  with
raumatic  exposure  of  the  wound,  it  is  advised  to  search
or  micro-organisms  of  the  Nocardia  family,  nontuberculous
ycobacteria  and  fungal  infection.  Patients  having  traveled
o  tropical  countries  should  be  screened  for  Burkholderia
seudomallei,  chromoblastomycosis  and  Chromobacterium.
ycobacterium  marinum  should  be  screened  for  in  cases
f  trauma  in  contaminated  water  (sea,  lake,  aquarium  or
wimming  pool).  In  the  same  way,  patients  having  wounded
hemselves  in  a  spa  swimming  pool  or  bath  should  be
creened  for  Pseudomonas  aeruginosa.
If  patients  have  been  in  contact  with  animals  such  as  pigs,
ea  ﬁsh  and  poultry,  they  should  be  tested  for  Erysipelothrix
husiopathiae  which  causes  erysipeloid-like  lesions.  Patients
aving  been  bitten,  especially  by  dogs  or  cats,  should
e  screened  for  bacteria  such  as  Pasteurella  multocida
i
n
a
malls, skin thickening and changes to subcutaneous fat.
nd  Capnocytophaga.  Human  bite  wounds  can  lead  to
nﬂammation  due  to  Eikenella  corrodens.  Patients  treated
ith  immunosuppressant  drugs,  such  as  HIV-positive  and
ransplant  patients,  should  be  tested  for  Gram-negative
acteria  such  as  Nocardia  and  Crytococcus  neoformans.
atrogenic infections
ost-invasive  procedure  infections  following  breast  surgery
r  interventional  radiology  procedures  account  for  a  sub-
tantial  proportion  of  breast  infections  [11].  In  these  cases,
atient  questioning  generally  provides  clear  information  and
iagnosis  is  usually  not  a  problem.
ractical measures, diagnostic approach
nd  core therapy for breast inﬂammation
adiologists  examining  women  consulting  for  breast  inﬂam-
ation  should  ﬁrst  question  the  patient  to  obtain  any
nformation  that  might  help  diagnose  the  condition  [19].  The
ircumstances  of  the  onset  of  inﬂammation,  for  example
uring  breast-feeding,  after  breast  surgery  or  biopsy,  will
bviously  help  to  orientate  the  diagnostic  approach.  It  is
mportant  to  obtain  information  about  the  duration  of  the
atient’s  breast  inﬂammation.  Recent  and  sudden  onset  of
nﬂammation  is  generally  not  caused  by  inﬂammatory  carci-
oma.  However  in  cases  with  symptoms  that  appeared  subtly
nd  progressed  quite  slowly,  the  diagnosis  of  breast  cancer
ust  be  suspected  and  excluded  with  certainty.
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Figure 17. Infection of a breast cyst. a: mammogram, MLO view, shows an opaque area with well-deﬁned borders in the upper quadrant
(arrow); b: enlargement of image (a) shows an opacity with well-deﬁned borders measuring approximately 1 cm; c: ultrasound of the upper
part of the left breast shows a cystic lesion consistent with the opacity on the mammogram; d: ultrasound of the upper part of the left
breast of the same patient as in images (a, b, c), performed 4 months after the onset of left mastitis. Ultrasound images show that cystic
lesions have disappeared, but a poorly deﬁned hypoechoic area has appeared and is associated with hyperechogenicity of breast fat; e:
percutaneous puncture performed to obtain histological and bacteriological specimens evidenced breast abscess.
Figure 18. Infected cyst. Normal right mammogram. Left mammogram reveals signs of breast inﬂammation with a centrally-located mass.
Three-centimeter hypoechoic nodule with thick walls consistent with the inﬂamed region. Puncture evidenced a superinfected cyst.
1060  
Figure 19. Localized granulomatous mastitis. Fifty-two-year-old
patient treated for 4 months for inﬂammatory episodes, patient
status after 3 inefﬁcacious antibiotic therapies. Breast ultrasound
shows marked skin thickening and hypoechoic ﬂuid collection with
poorly deﬁned borders in the subcutaneous breast tissue. Fat-
saturated T1-weighted MR image after intravenous administration
of a gadolinium chelate shows extensive tissue enhancement in the
right breast.
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Figure 20. Granulomatous mastitis: same patient as Fig. 19. Histologi
inﬂammatory inﬁltration with developing granulomatous lesions. Enlarge
loma. Fat-saturated T1-weighted MR image obtained after intravenous ad
Fat-saturated T1-weighted MR image obtained after intravenous admini
months after systemic corticosteroid therapy shows complete disappearD.  Lepori
Next,  the  patient  should  be  examined  as  thoroughly
s  possible  using  the  appropriate  imaging  techniques  that
epend  on  the  patient  and  the  circumstances.  Mammogra-
hy  should  be  proposed  to  all  women  aged  over  30  years
ith  breast  inﬂammation  and  should  be  combined  with
ltrasound  examination  of  both  breasts  and  lymph  node
tations.
Taken  together  with  the  patient’s  history  and  clinical
xamination,  imaging  ﬁndings  generally  spur  the  clini-
ian’s  suspicion  in  cases  of  inﬂammatory  carcinoma.  When
nﬂammatory  carcinoma  is  suspected,  tissue  samples  should
apidly  be  taken  from  suspicious  zones.  Once  the  diagno-
is  is  conﬁrmed,  breast  MRI  is  indicated  to  determine  the
xtent  of  cancer  spread  and  possible  lymph  node  and/or
ontralateral  involvement.
If initial  radiological  assessment  does  not  reveal  clear
igns  of  carcinoma,  radiologists  should  search  for  possible
uid  collections.  If  detected  by  initial  ultrasound  exami-
ation,  samples  of  breast  ﬂuid  collections  should  be  taken
or  bacteriological  testing  and,  if  possible,  tissue  samples
hould  also  be  collected.  In  patients  with  signiﬁcant  ﬂuid
uild-up,  collections  should  be  drained  during  this  inter-
entional  procedure.  Drug  treatment  as  outlined  below
ay  thus  be  initiated  rapidly.  Such  treatment  may  be  pre-
cribed  by  the  radiologist,  with  the  attending  physician’s
onsent.  Both  the  treatment  and  diagnostic  approach  should
e  reviewed  and  possibly  adjusted  when  the  bacteriolog-
cal/histological  results  become  available.  The  patient  is
nstructed  to  consult  her  doctor  again  in  the  event  of  rapid
linical  deterioration.
She  should  be  seen  again  about  1  week  after  the  start  of
reatment  to  determine  whether  symptoms  have  improved.
cal sections of a sample collected by percutaneous puncture shows
ment of image (a) reveals presence of giant cells within the granu-
ministration of a gadolinium chelate prior to corticosteroid therapy.
stration of a gadolinium chelate of the same zone as image (c), 3
ance of inﬂammatory lesions.
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Figure 21. Pseudotumoral granulomatous mastitis in a 55-year-old patient with palpable masses of the right breast. Ultrasound exami-
nation shows multiple breast lesions with axillary lymphadenopathy. Patient was referred for breast MRI and puncture biopsy for suspected
multicentric breast cancer. Fat-saturated T1-weighted MR image obtained after intravenous administration of a gadolinium chelate shows
enhancement of the dermis and subcutaneous layer. b: fat-saturated T1-weighted MR image obtained after intravenous administration of
a gadolinium chelate shows extensive enhancement of breast tissue with small nodular areas consistent with multiple microabscesses;
c: fat-saturated T1-weighted MR image obtained after intravenous administration of a gadolinium chelate shows the spread of zones of
contrast enhancement; d: fat-saturated T1-weighted MR image obtained after intravenous administration of a gadolinium chelate shows
right axillary lymph node enlargement (arrowhead).
Figure 22. Practical procedure for investigating and treating inﬂammatory breast disease.
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Take-home  messages
• The  radiologist  must  be  familiar  with  the  radiological
signs  of  breast  inﬂammation:
◦ thickening  of  the  skin,
◦ hyperechoic  fat,
◦ visibility  of  subcutaneous  lymphatic  vessels,
◦ increased  vascularization,
◦ lactiferous  duct  changes,
◦ ﬂuid  collections  and  lymphadenopathies.
• Inﬂammatory  cancer  must  be  recognized  and
diagnosed  without  fail:
◦ frequent  signiﬁcant  skin  edema,
◦ gradual  progression  of  the  condition,
◦ lesions  that  are  sometimes  difﬁcult  to  identify.
• Radiologists  should  search  for  speciﬁc  forms  of
inﬂammation:
◦ inﬂammation  of  the  nipple-areola  region,
including  Zuska’s  disease,
◦ granulomatous  mastitis,
◦ infections  due  to  speciﬁc  micro-organisms.
• Percutaneous  sampling  should  be  implemented  on  a
regular  basis:
◦ diagnosis  of  various  forms  of  breast  cancer,
◦ diagnostic  bacteriological  testing,  including
unusual  species,
◦ drainage  of  ﬂuid  collections.
• Appropriate  drug  treatment  should  be  initiated  by
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f  so,  drug  treatment  should  be  continued.  Imaging  should
e  performed  again  about  3  months  after  the  onset  of  symp-
oms;  the  aim  of  it  being  to  examine  the  patient  outside
f  the  clinically  acute  phase,  obtain  quality  images  of  the
ormerly  inﬂamed  breast  and  conﬁrm  the  absence  of  suspi-
ious  radiological  ﬁndings  that  could  reﬂect  breast  cancer.
ndeed,  the  initial  acute  phase  assessment  might  not  have
een  of  optimal  quality  or  sensitivity,  notably  due  to  lesser
reast  compression  because  of  the  pain  it  causes  to  patients
ith  an  inﬂamed  breast.
If the  radiologist  cannot  evidence  ﬂuid  collection  during
he  initial  acute  phase  examination  but  visualizes  only  signs
f  inﬂammation,  targeted  percutaneous  sampling  is  in  prin-
iple  not  possible  or  recommended.  In  such  cases,  empiric
rug  treatment  should  be  initiated  according  to  the  rec-
mmendations  provided  below.  The  patient  should  be  seen
gain  7  days  later  and  drug  treatment  continued  if  clear  clin-
cal  improvement  is  observed.  Follow-up  imaging  should  be
arried  out  for  all  patients  about  3  months  after  the  onset
f  symptoms.
If,  at  the  time  of  the  ﬁrst  early  follow-up  visit  (7  days),  no
lear  signs  of  clinical  improvement  are  observed,  then  the
atient  should  be  referred  again  to  the  radiologist  in  order  to
ollect  samples  from  zones  of  tissue  showing  inﬂammation.
hese  samples  should  allow  for  more  accurate  diagnosis  and
djustment  of  treatment  if  necessary.
It  is  essential  that  both  the  radiologist  and  the  attend-
ng  physician  inform  the  patient  that  any  changes  in  the
rogress  of  her  condition,  such  as  a  rapid  worsening  or  recur-
ence  after  discontinuation  of  treatment,  should  incite  her
o  consult  again  as  soon  as  possible  (Fig.  22).
roposed drug regimen
he  radiologist  should  be  able,  with  the  attending  clini-
ian’s  consent,  to  propose  and  implement  drug  treatment.
rug  treatment  is  usually  based  on  antibiotic  therapy  and
reatment  with  systemic  and  local  anti-inﬂammatory  drugs
19,20].
Antibiotic  therapy  should  bear  in  mind  the  patient’s  his-
ory,  in  particular  an  allergy  to  penicillin.  One  gram  of
moxicillin/clavulanate  orally  2  times/day  is  the  ﬁrst  choice
ntibiotic  therapy.  Patients  with  known  allergy  to  penicillin
hould  receive  600  mg  of  clindamycin  3  times/day.  Treat-
ent  should  be  continued  for  about  2  weeks  even  if  the
ymptoms  disappear  quickly  after  initiation  of  treatment.
his  prolonged  period  of  treatment  is  justiﬁed  by  the  rela-
ively  poor  penetration  of  antibiotics  in  breast  tissue.
Systemic  anti-inﬂammatory  treatment  is  based  on  non-
teroidal  anti-inﬂammatory  drugs,  such  as  ibuprofen,  at  a
ose  of  400  mg,  3  times/day.  Gastric  protection  can  be
rescribed  depending  on  the  patient’s  history  of  use  of  anti-
nﬂammatory  drugs.
Local  anti-inﬂammatory  treatment  may  also  be  imple-
ented  either  via  creams  or  gels  containing  non-steroidal
nti-inﬂammatory  drugs,  or  via  patches  containing  the
ame  substances  that  are  applied  to  the  skin  where  the
nﬂammation  is  most  pronounced.  Local  anti-inﬂammatory
pplication  should  be  renewed  2  times/day.  Local  cooling
an  also  help.the  radiologist.
linical case
linical history
 healthy  46-year-old  woman  with  no  noteworthy  history  of
reast  disease  consulted  her  gynecologist  for  a  painful,  pal-
able,  nodule  in  the  right  periareolar  region  that  appeared
 days  before.  She  had  no  family  history  of  breast  cancer.
linical  examination  revealed  localized  skin  thickening  of
he  areola  over  an  area  of  3  cm2 next  to  a  palpable  plaque.
igns  of  inﬂammation  in  the  form  of  red  and  locally  hot  skin
ere  detected.  No  nipple  discharge  or  ﬁstula  was  visible.  No
xillary  lymph  node  enlargement  was  present  (Fig.  23).
uestions
.  Do  the  patient’s  clinical  history  and  imaging  ﬁndings  sug-
gest  inﬂammatory  carcinoma?
.  What  do  you  think  the  linear  structure  within  the  hypoe-
choic  collection  is?
.  What  is  your  diagnosis?
nswers
.  The  patient’s  clinical  history,  together  with  the  rapid
onset  of  localized  symptoms  with  clear  inﬂammatory
signs  suggest  that  this  is  not  a  case  of  breast  can-
cer  but  rather  an  inﬂammatory  lesion,  perhaps  of
infectious  origin.  Imaging  also  shows  localized  ﬁnd-
ings.  Neither  mammography  nor  ultrasound  detected
the  typical  lesions  associated  with  breast  cancer.  The
Inﬂammatory  breast  disease:  The  radiologist’s  role  1063
Figure 23. Clinical case: 43-year-old patient with no history of medical problems or breast disease. No family history. Mammogram of
the right breast (MLO view) shows no mammographic abnormalities but a thickening of the skin in the periareolar region. Enlarged view
of image (a) shows skin thickening in the periareolar region. Ultrasound examination shows skin thickening and hypoechoic ﬂuid collection
with poorly deﬁned borders. A linear hyperechoic structure can be seen within the ﬂuid collection.
D
T
c
Rpresence  of  a  ﬂuid  collection  suggests  an  inﬂammatory
condition.
2.  The  linear  structure  within  a  ﬂuid  collection  suggests  the
presence  of  a  foreign  body.  Due  to  the  absence  of  previ-
ous  breast  conditions,  the  structure  cannot  be  a  foreign
body  introduced  during  biopsy  or  surgery.  Owing  to  its
proximity  with  the  areolar  region,  it  could  be  a  hair.
3.  Diagnosis  can  be  made  by  questioning  the  patient  fur-
ther.  Indeed,  the  patient  is  a  hairdresser  and  hairdressers
using  clippers  when  cutting  hair  have  been  known  to
develop  pilonidal  breast  sinuses  following  penetration  of
sharp  fragments  of  hair.  The  patient’s  condition  is  due
to  reaction  to  a  foreign  body  that  may  have  become
superinfected  [21,22].  Such  sinuses  are  usually  reported
in  the  cleavage  region,  typically  in  the  internal  breast
quadrants.
Diagnosis
Superinfected  pilonidal  breast  sinus.  It  is  a  condition
observed  sometimes  in  hairdressers.
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